Early Cancer Institute Seminar: Professor Sarah Teichmann
Few tickets left

Early Cancer Institute Seminar: Professor Sarah Teichmann

Seminar presented by Professor Sarah Teichmann of the Stem Cell Institute: Mapping human tumours: one cell at a time

By Cancer Research UK Cambridge Centre

Date and time

Tue, 14 May 2024 12:30 - 14:00 GMT+1

Location

Clifford Allbutt Lecture Theatre

307 Hills Road Cambridge CB2 0SP United Kingdom

About this event

  • 1 hour 30 minutes

The seminar series from the Early Cancer Institute aims to connect researchers in the early cancer detection and diagnosis space to share knowledge and spark collaboration. Join fellow researchers for lunch and an opportunity to network.

On Tuesday 14th May we welcome Sarah Teichmann, Professor of Stem Cell Medicine at the Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, to give a talk: 'Mapping human tumours: one cell at a time'


DIFFERENT VENUE:
Please note, this event will take place at the Clifford Allbutt Lecture Theatre, CB2 0SP (NOT the Early Cancer Institute)

Lunch is provided from 12:30pm, the talk will begin at 1.00pm followed by a Q&A. Please ensure you arrive promptly.


Speaker Biography:

Sarah did her PhD at the MRC Laboratory of Molecular Biology, Cambridge, and was a Beit Memorial Fellow at University College London. She started her group at the MRC-LMB in 2001, and moved to the Wellcome Genome Campus in 2013, where her group was joint between the EMBL-EBI and the Wellcome Sanger Institute. In 2016 she was appointed Head of the Cellular Genetics programme at the Sanger. Sarah is co-founder and co-leader of the international Human Cell Atlas consortium, which aims to create reference maps for cells across all human tissues and co-directs the CIFAR MacMillan Multiscale Human research programme. In 2024, Sarah took up a Chair in Stem Cell Medicine at the University of Cambridge (Cambridge Stem Cell Institute & Dept Medicine).

Organised by

The Cancer Research UK Cambridge Centre unites over 1,000 world-leading biologists, chemists, physicists, engineers, mathematicians, computer scientists, clinicians, nurses and allied healthcare professionals from across Cambridge, UK to tackle cancer from every angle.

Our mission is to end death and disease caused by cancer through research, treatment and education. We are detecting cancer at its earliest stage and are developing personalised treatments for every patient through facilitating new collaborations and driving the translation of new scientific discoveries into clinical applications to improve patient care. By working together across a range of different disciplines, our members are breaking down the barriers between the laboratory and the clinic, enabling patients to benefit from the latest innovations in cancer science.